ATH 5 Oct 2026, 10:03 AM

Alterity Presents New Analyses of ATH434 Phase 2 Data in MSA

Alterity Therapeutics Ltd

Sign in to open PDF

No summary is available for this announcement — sign in to read the PDF in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in